20
IRUS TotalDownloads
Altmetric
A novel class of sulphonamides potently block malaria transmission by targeting a Plasmodium vacuole membrane protein
File | Description | Size | Format | |
---|---|---|---|---|
Dis Model Mech 2023, Published.pdf | Published version | 5.63 MB | Adobe PDF | View/Open |
Title: | A novel class of sulphonamides potently block malaria transmission by targeting a Plasmodium vacuole membrane protein |
Authors: | Yahiya, S Saunders, CN Hassan, S Straschil, U Fischer, OJ Rueda-Zubiaurre, A Haase, S Vizcay-Barrena, G Famodimu, MT Jordan, S Delves, MJ Tate, EW Barnard, A Fuchter, MJ Baum, J |
Item Type: | Journal Article |
Abstract: | Phenotypic cell-based screens are critical tools for discovering candidate drugs for development, yet identification of the cellular target and mode of action of a candidate drug is often lacking. Using an imaging-based screen, we recently discovered an N-[(4-hydroxychroman-4-yl)methyl]-sulphonamide (N-4HCS) compound, DDD01035881, that blocks male gamete formation in the malaria parasite life cycle and subsequent transmission of the parasite to the mosquito with nanomolar activity. To identify the target(s) of DDD01035881, and of the N-4HCS class of compounds more broadly, we synthesised a photoactivatable derivative, probe 2. Photoaffinity labelling of probe 2 coupled with mass spectrometry identified the 16 kDa Plasmodium falciparum parasitophorous vacuole membrane protein Pfs16 as a potential parasite target. Complementary methods including cellular thermal shift assays confirmed that the parent molecule DDD01035881 stabilised Pfs16 in lysates from activated mature gametocytes. Combined with high-resolution, fluorescence and electron microscopy data, which demonstrated that parasites inhibited with N-4HCS compounds phenocopy the targeted deletion of Pfs16 in gametocytes, these data implicate Pfs16 as a likely target of DDD01035881. This finding establishes N-4HCS compounds as being flexible and effective starting candidates from which transmission-blocking antimalarials can be developed in the future. |
Issue Date: | 1-Feb-2023 |
Date of Acceptance: | 13-Dec-2022 |
URI: | http://hdl.handle.net/10044/1/101971 |
DOI: | 10.1242/dmm.049950 |
ISSN: | 1754-8403 |
Publisher: | The Company of Biologists |
Start Page: | 1 |
End Page: | 20 |
Journal / Book Title: | Disease Models & Mechanisms |
Volume: | 16 |
Issue: | 2 |
Copyright Statement: | © 2023. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
Publication Status: | Published online |
Online Publication Date: | 2023-01-30 |
Appears in Collections: | Chemistry Biological and Biophysical Chemistry Faculty of Natural Sciences |
This item is licensed under a Creative Commons License